Sunder Biomedical Tech Co

Sunder Biomedical Tech Co Receivables

The Accounts Receivable of Sunder Biomedical Tech Co (4115.TWO) as of Oct 25, 2026 is 223.28 M TWD. In the previous year, Accounts Receivable was 244.66 M TWD — a change of -8.74% (lower).

Receivables

223.28 MTWD

YoY

-8.74%

Last updated:

Accounts Receivable of Sunder Biomedical Tech Co is 2024 223.28 M TWD. Accounts Receivable of Sunder Biomedical Tech Co was 2023 244.66 M TWD. It decreases by -8.74% lower compared to the previous year.

The Sunder Biomedical Tech Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2019
221.70 M TWD
Jan 1, 2020
230.92 M TWD
Jan 1, 2021
282.96 M TWD
Jan 1, 2022
241.84 M TWD
Jan 1, 2023
244.66 M TWD
Jan 1, 2024
223.28 M TWD
The Sunder Biomedical Tech Co Receivables history
YEARReceivablesYoY
223.28 MTWD-8.74%
244.66 MTWD+1.16%
241.84 MTWD-14.53%
282.96 MTWD+22.54%
230.92 MTWD+4.16%
221.70 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co Ltd manufactures and sells medical consumables including blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, and protective covers. The company also produces laparoscopic smoke filters, suction sets, pick-up bags, and medical grade materials such as PVC pellets, NON-diethylhexyl phthalate (DEHP) PVC, and other medical components. Additionally, Sunder Biomedical offers sterilization and laboratory services, along with foundry services for masks, tubes, and nucleic acid extraction well tray consumables. The primary buyers of Sunder Biomedical's products are healthcare facilities, hospitals, and medical institutions requiring disposable medical equipment and supplies. These clients purchase medical consumables for routine procedures, surgical operations, and patient care. The company's focus on medical grade materials ensures compliance with healthcare standards, making its products essential for medical professionals. Sunder Biomedical's revenue streams include direct sales of medical consumables, sterilization services, and foundry services for specialized medical components. The company targets the healthcare sector, particularly hospitals and clinics, where demand for reliable, high-quality disposable medical products is consistent. By providing a comprehensive range of medical supplies, Sunder Biomedical caters to the operational needs of healthcare providers across various medical specialties. Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

Accounts Receivable of Sunder Biomedical Tech Co is 223.28 M TWD in 2024.

Accounts Receivable of Sunder Biomedical Tech Co changed from 244.66 M TWD to 223.28 M TWD, representing a -8.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Sunder Biomedical Tech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co